|
Re: What impact would a PR like this have?
|
2
|
Resverlogix Corp.
|
Jan 29, 2019 04:30PM
|
|
Re: A few comments
|
2
|
Resverlogix Corp.
|
Jan 12, 2017 04:22PM
|
|
Re: Potential Scope of Indications for Apabetalone (selective BRD/BD inhibition)
|
2
|
Resverlogix Corp.
|
Nov 14, 2022 05:12PM
|
|
Re: Warrants conversion!
|
2
|
Resverlogix Corp.
|
Nov 27, 2019 01:01PM
|
|
NY presentation
|
2
|
Resverlogix Corp.
|
Sep 07, 2018 02:37PM
|
|
Re: Next News Release
|
2
|
Resverlogix Corp.
|
May 16, 2017 02:33AM
|
|
Re: Why
|
2
|
Resverlogix Corp.
|
May 14, 2021 01:10AM
|
|
Re: New Zenith MD&A Posted on SEDAR
|
2
|
Zenith Epigenetics
|
Sep 30, 2017 05:33AM
|
|
Re: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
|
2
|
Zenith Epigenetics
|
Apr 20, 2020 02:59PM
|
|
Re: Reverse Split, the good, bad and in between....
|
2
|
Resverlogix Corp.
|
Aug 15, 2018 11:48AM
|
|
Re: "So if you get fantastic results in a Brazilian COVID-19 clinical trial, be prepared..." is my read.
|
2
|
Resverlogix Corp.
|
Jul 30, 2021 05:18PM
|
|
Re: Dr. Kausik Ray will deliver the AHA Late Breaking Presentation on BETonMACE
|
2
|
Resverlogix Corp.
|
Nov 03, 2019 01:04PM
|
|
Re: Buyers need sellers....why I think delivery failures are important
|
2
|
Resverlogix Corp.
|
Nov 09, 2019 12:38PM
|
|
Re: What we know and what we don't.....
|
2
|
Resverlogix Corp.
|
May 16, 2019 05:23PM
|
|
Welcome to the RVX Hub bionug
|
2
|
Resverlogix Corp.
|
Jan 06, 2020 05:28PM
|
|
Re: Additional Reports Of Exempt Distribution.
|
2
|
Zenith Epigenetics
|
Jun 05, 2024 10:55PM
|
|
Re: Reviewing post from sometime back in 2015
|
2
|
Resverlogix Corp.
|
Jun 12, 2017 10:51AM
|
|
Re: BETonMACE Placebo Estimate
|
2
|
Resverlogix Corp.
|
Feb 20, 2019 05:32PM
|
|
Re: CKD & VCD clarification
|
2
|
Resverlogix Corp.
|
Jun 03, 2019 12:49PM
|
|
Re: ... removed posts????
|
2
|
Resverlogix Corp.
|
Oct 30, 2017 07:37PM
|
